Jacqueline Howard DDS+FollowBreakthrough Combo for Tough Myeloma CasesA new drug combo (talquetamab + teclistamab) is making waves for patients with super-tough, relapsed multiple myeloma that’s spread outside the bones. In a recent trial, nearly 80% of patients responded, and over half saw their cancer disappear completely! The results are way better than previous treatments, especially for those with few options left. Side effects were pretty intense, but this could be a game-changer for a group that’s usually out of luck. #Health #BodyHealth #Myeloma10Share
rachel60+FollowBreakthrough Myeloma Combo Shows Real PromiseA new combo therapy is shaking up the fight against aggressive myeloma! Patients with tough-to-treat extramedullary myeloma saw major improvements when treated with two bispecific antibodies—teclistamab and talquetamab. Nearly 79% responded to the treatment, and survival rates soared compared to standard options. Side effects? Mostly manageable. This could be a total game-changer for people who’ve run out of options. Science for the win! #Health #BodyHealth #Myeloma00Share
